XML 36 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Derivative Instruments (Tables)
9 Months Ended
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments
As of December 31, 2022, the Company has the following derivative contracts recorded at fair value in the condensed consolidated balance sheets:
Designated
Derivative Contracts
Non-Designated Derivative ContractsTotal
Notional value$33,525 $— $33,525 
Fair value recorded in other current assets185 — 185 
Fair value recorded in other accrued expenses(498)— (498)
Schedule of Location and Amount of Gains and Losses Related to Derivatives Designated as Hedging Instruments
The following table summarizes the effect of Designated Derivative Contracts and the related income tax effects of unrealized gains or losses recorded in the condensed consolidated statements of comprehensive income for changes in AOCL:
Three Months Ended December 31,Nine Months Ended December 31,
2022202120222021
(Loss) Gain recorded in Other comprehensive income$(1,270)$105 $1,535 $4,154 
Reclassifications from Accumulated other comprehensive loss into net sales(1,479)(2,107)(1,848)(2,869)
Income tax benefit (expense) in Other comprehensive income666 485 76 (311)
Total$(2,083)$(1,517)$(237)$974 
Schedule of Location and Amount of Gains and Losses Related to Derivatives Not Designated as Hedging Instruments
The following table summarizes the effect of Non-Designated Derivative Contracts recorded in the condensed consolidated statements of comprehensive income:
Three Months Ended December 31,Nine Months Ended December 31,
2022202120222021
(Loss) Gain recorded in SG&A expenses$(398)$(157)$1,518 $591